May 2020 Clinical Watch Newsletter

June 17, 2020

In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofibromas. Lastly, we review claims data to identify potential users for a new option to treat “off” episodes associated with Parkinson’s disease.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020

Next Flipbook
2018 Customer Experience Report for Telecoms
2018 Customer Experience Report for Telecoms

Customer expectations have grown exponentially. Companies must deliver seamless, real-time, personalized ex...